Procedures for Microencapsulation of Enzymes, Cells and Genetically Engineered Microorganisms
- 1 January 2001
- journal article
- Published by Springer Science and Business Media LLC in Molecular Biotechnology
- Vol. 17 (3), 249-260
- https://doi.org/10.1385/mb:17:3:249
Abstract
Methods to microencapsulate enzyme, cells, and genetically engineered cells have been described in this article. More specific examples of enzyme encapsulation include the microencapsulation of xanthine oxidase for Lesch-Nyhan disease; phenylalanine ammonia lyase for pheny, ketonuria and microencapsulation of multienzyme systems with cofactor recycling for multistep enzyme conversions. Methods for cell encapsulation include the details for encapsulating hepatocytes for liver failure and for gene therapy. This also includes the details of a novel two-step method for encapsulation of high concentrations of smaller cells. Another new approach is the detailed method of the encapsulation of genetically engineered Escherichia coli DH5 cells for lowering urea, ammonia, and other metabolites in kidney or, liver failure and other diseases.Keywords
This publication has 34 references indexed in Scilit:
- Bowel as a kidney substitute in renal failureAmerican Journal of Kidney Diseases, 1996
- Submicron Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: Preparation and CharacterizationArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1996
- Characterization of free and alginate–polylysine–alginate microencapsulated Erwinia herbicola for the conversion of ammonia, pyruvate, and phenol into L‐tyrosineBiotechnology & Bioengineering, 1995
- Kinetic Analysis of UDP‐Glucuronosyltransferase in Bilirubin Conjugation by Encapsulated Hepatocytes for Transplantation into Gunn RatsArtificial Organs, 1995
- Polydisperse Dextran as a Diffusing Test Solute to Study the Membrane Permeability of Alginate Polylysine MicrocapsulesBiomaterials, Artificial Cells and Immobilization Biotechnology, 1993
- Effects of Hepatic Stimulatory Factor Released from Free or Microencapsulated Hepatocytes on Galactosamine Induced Fulminant Hepatic Failure Animal ModelBiomaterials, Artificial Cells and Immobilization Biotechnology, 1991
- Hepatocytes Immobilised by Microencapsulation in Artificial Cells: Effects on Hyperbilirubihemia in Gunn RatsBiomaterials, Artificial Cells and Artificial Organs, 1989
- Preparation and Characterisation of Xanthine Oxidase Immobilised by Microencapsulation in Artificial Cells for the Removal of HypoxanthineBiomaterials, Artificial Cells and Artificial Organs, 1989
- The Viability and Regeneration of Artificial Cell Microencapsulated Rat Hepatocyte Xenograft Transplants in MiceBiomaterials, Artificial Cells and Artificial Organs, 1988
- Stablisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehydeBiochemical and Biophysical Research Communications, 1971